A Study of RC48-ADC for the Treatment of HER2-expressing Gynecological Malignancies
Clinical trial NCT04965519 · UNKNOWN
Trial details
- NCT number
- NCT04965519
- Sponsor
- RemeGen Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-21
- Primary completion
- 2024-10-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.